"EMA will now review all available data to assess whether this emerging information has an impact on the balance of benefits and risks of Tavneos," said the EU regulator. "The agency will then issue a ...
Alzheimer’s might not just attack the brain, it could trick it into deleting memories. A surprising twist changes everything.
Alzheimer’s may destroy memory by flipping a single molecular switch that tells neurons to prune their own connections. Researchers found that both amyloid beta and inflammation converge on the same ...
Alzheimer's disease is known for one devastating effect above all others. It steadily destroys brain cells and the connections between them, breaking ...
Sugar Clean Drops is formulated according to a multi-mechanism philosophy characteristic of contemporary metabolic wellness supplements. GlucoTnic Research describes its approach as ingredient-first, ...
Proteinuria (protein in urine) is common with complement 3 glomeropathy and is a strong predictor of disease progression and end-stage kidney failure.
FDA Fast Track designation has been granted to CTx001 for Geographic Atrophy secondary to Age-related Macular Degeneration CTx001 is an investigational AAV-based gene therapy designed to modulate ...
Scientists have spotted a new variety of riled-up microglia that drives swelling in the human brain. In the November 18 Neuron, researchers from China led by Haixiao Liu, Shunnan Ge, and Yan Qu at ...
CTx001 is an investigational AAV-based gene therapy designed to modulate multiple pathways of the complement system Opti-GAIN is a first-in-human trial to evaluate the safety, tolerability, and ...
FDA approval enables Complement Therapeutics to start the Opti-GAIN phase 1/2 trial for CTx001 in GA secondary to AMD. CTx001 is an AAV-based gene therapy delivering a truncated Complement Receptor 1 ...
The company can now initiate the Opti-GAIN (Optimized Geographic Atrophy INterventional) phase 1/2 clinical trial. The US Food and Drug Administration (FDA) has approved the Investigational New Drug ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. The complement 3a receptor (C3aR) is a G-protein-coupled receptor (GPCR) involved in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results